Thomas Hanslik Selected Research

1- (3,4- dihydroxyphenyl)- 2- (3- (4- carbamylphenyl)- 1- methylpropylamino)ethanol

1/2019

Risk factors for seasonal influenza virus detection in stools of patients consulting in general practice for acute respiratory infections in France, 2014-2016.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Hanslik Research Topics

Disease

18	Human Influenza (Influenza) 01/2020 - 10/2009
11	Infections 11/2019 - 05/2005
4	COVID-19 01/2022 - 01/2021
3	Herpes Zoster 01/2022 - 02/2012
3	Gastroenteritis 11/2019 - 10/2013
3	Vasculitis (Vasculitides) 10/2017 - 02/2007
2	Chickenpox 03/2022 - 09/2003
2	Hemorrhage 01/2022 - 01/2004
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020 - 01/2019
2	Urinary Tract Infections (Urinary Tract Infection) 02/2017 - 09/2015
2	Systemic Scleroderma (Systemic Sclerosis) 12/2014 - 12/2011
2	Neoplasms (Cancer) 12/2014 - 12/2007
2	Autoimmune Diseases (Autoimmune Disease) 08/2014 - 03/2011
2	Pain (Aches) 04/2013 - 02/2012
2	Fever (Fevers) 09/2012 - 12/2007
1	Severe Acute Respiratory Syndrome 01/2022
1	Neuralgia (Stump Neuralgia) 01/2022
1	Hip Fractures (Intertrochanteric Fractures) 01/2021
1	Osteoporotic Fractures 01/2021
1	Cognitive Dysfunction 01/2020
1	Bronchitis 01/2020
1	Nasopharyngitis 01/2020
1	Otitis Media with Effusion 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Lyme Disease (Disease, Lyme) 01/2019
1	Dementia (Dementias) 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Venous Thromboembolism 01/2019
1	Immunoglobulin G4-Related Disease 10/2017
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 09/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2016
1	Hearing Loss (Hearing Impairment) 09/2016
1	Sensorineural Hearing Loss 09/2016
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 09/2016
1	Thrombocytopenia (Thrombopenia) 09/2016
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 04/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2015
1	Tetanus 01/2015
1	Pulmonary Hypertension 12/2014
1	HIV Infections (HIV Infection) 08/2014
1	Nausea 10/2013
1	Yellow Fever 09/2013
1	Ankylosing Spondylitis 04/2013
1	Urethritis 05/2011
1	Chronic Disease (Chronic Diseases) 03/2011

Drug/Important Bio-Agent (IBA)

11	VaccinesIBA 01/2022 - 02/2009
6	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2017 - 03/2011
5	Pharmaceutical PreparationsIBA 01/2022 - 09/2012
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 05/2011
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2017 - 02/2007
4	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2016 - 12/2007
3	Antiviral Agents (Antivirals)IBA 01/2019 - 02/2012
3	Immunosuppressive Agents (Immunosuppressants)IBA 08/2014 - 12/2007
2	Immunoglobulin G (IgG)IBA 01/2022 - 07/2021
2	AnticoagulantsIBA 01/2022 - 01/2019
2	AntibodiesIBA 07/2021 - 12/2014
2	Proton Pump InhibitorsIBA 11/2019 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2019 - 04/2015
2	Viral RNAIBA 01/2019 - 12/2015
1	Acyclovir (Aciclovir)FDA LinkGeneric 03/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	ORALIT (ORS)IBA 01/2022
1	Valacyclovir (Valtrex)FDA LinkGeneric 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Diphosphonates (Bisphosphonates)IBA 01/2021
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2020
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2020
1	BenzodiazepinesIBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	Memantine (Namenda)FDA Link 01/2020
1	Nucleic AcidsIBA 06/2019
1	1- (3,4- dihydroxyphenyl)- 2- (3- (4- carbamylphenyl)- 1- methylpropylamino)ethanolIBA 01/2019
1	Hypnotics and Sedatives (Sedatives)IBA 01/2019
1	AntipyreticsIBA 11/2017
1	CI 22IBA 10/2017
1	Antiphospholipid AntibodiesIBA 09/2016
1	AutoantibodiesIBA 09/2016
1	Immunologic Factors (Immunomodulators)IBA 12/2015
1	SolutionsIBA 01/2015
1	cyclo(Arg-Pro) (CI 4)IBA 01/2015
1	Neuraminidase (Sialidase)IBA 01/2015
1	Immunoglobulins (Immunoglobulin)IBA 12/2014
1	AntiemeticsIBA 10/2013
1	Prostaglandins AIBA 04/2013
1	2,5-dichloro-4-bromophenol (B 2)IBA 06/2012
1	Carbon MonoxideIBA 12/2011
1	DNA (Deoxyribonucleic Acid)IBA 08/2011
1	Ciprofloxacin (Cipro)FDA LinkGeneric 05/2011
1	Azithromycin (Zithromax)FDA LinkGeneric 05/2011
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 05/2011

Therapy/Procedure

8	Therapeutics 01/2022 - 09/2003
1	Ambulatory Care (Outpatient Care) 01/2021
1	Emergency Treatment 09/2016
1	Duration of Therapy 04/2016
1	Highly Active Antiretroviral Therapy (HAART) 08/2014
1	Inappropriate Prescribing 10/2013